Universe Pharmaceuticals Inc (UPC) — Financial Flexibility Index
Universe Pharmaceuticals Inc (UPC) has a Financial Flexibility Index of -0.57x as of December 2025. Free cash flow of $-7.44 Million (operating CF $-7.61 Million minus capex $169.99K) represents -1% of total liabilities ($13.17 Million). Check strategic asset allocation of Universe Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Universe Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Universe Pharmaceuticals Inc across 8 annual periods. See UPC working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Universe Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Universe Pharmaceuticals Inc. For the full company profile including market capitalisation, see UPC market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.36x | $-4.71 Million | $-5.05 Million | $13.17 Million | ▲ +12.3% |
| 2024 | -0.41x | $-9.14 Million | $-9.51 Million | $22.45 Million | ▼ -581.2% |
| 2023 | 0.08x | $1.16 Million | $1.12 Million | $13.75 Million | ▲ +191.0% |
| 2022 | -0.09x | $-1.22 Million | $-1.31 Million | $13.10 Million | ▼ -109.1% |
| 2021 | 1.02x | $11.48 Million | $-2.06 Million | $11.21 Million | ▲ +32.8% |
| 2020 | 0.77x | $6.17 Million | $6.12 Million | $8.00 Million | ▼ -68.4% |
| 2019 | 2.44x | $13.29 Million | $13.20 Million | $5.45 Million | ▲ +874.6% |
| 2018 | 0.25x | $4.60 Million | $4.46 Million | $18.40 Million | — |